BMRN
BIOMARIN PHARMACEUTICAL INC · Healthcare · Market cap $12.7B
Insiders sold $1.2M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 3, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Sep 3, 2026
Davis George Eric
BIOMARIN PHARMACEUTICAL INC (BMRN) has 30 SEC Form 4 filings (45 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 3 insiders at BIOMARIN PHARMACEUTICAL INC reported no open-market purchases and 5 open-market sales totaling $4.3M. Insiders have net sold $2.3M over the trailing 6 months. The most recent open-market filing is a sale of 17,557 shares by EVP, Chief Legal Officer Davis George Eric, dated Sep 2, 2026, worth $1.2M.
- Industry:Biotechnology
- CEO:Alexander Hardy
- Employees:3,221
- HQ:San Rafael, CA, US
- IPO:1999-07-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
Davis George EricFirst in 6 months | EVP, Chief Legal Officer | Sale | 17,557 | $1.2M | Sep 3 | -1.1% | SEC ↗ |
| EVP, Chief R&D Officer | Sale | 3,281 | $177K | May 11 | +24.9% | SEC ↗ | |
Guyer Charles GregFirst filing | EVP, Chief Technical Officer | Sale | 16,486 | $997K | Mar 12 | +11.2% | SEC ↗ |
Davis George EricFirst filing | EVP, Chief Legal Officer | Sale | 26,061 | $1.6M | Feb 26 | +7.5% | SEC ↗ |
Friberg Gregory RFirst filing | EVP, Chief R&D Officer | Sale | 6,326 | $382K | Feb 26 | +7.5% | SEC ↗ |
Congress trading BMRN 17 all-time
- DRep. Daniel GoldmanOther$1,001 - $15,0002023-03-06
- DRep. Ro KhannaSale$1,001 - $15,0002023-03-14
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-12-06
- DRep. Ro KhannaSale$1,001 - $15,0002022-05-10
- DRep. Josh S. GottheimerOther$1,001 - $15,0002021-10-18
- DRep. Gilbert Ray CisnerosPurchase$15,001 - $50,0002020-12-30
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does BMRN have?
BIOMARIN PHARMACEUTICAL INC (BMRN) has 30 SEC Form 4 filings (45 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for BMRN?
The most recent Form 4 filing for BMRN on Tracefour is dated Sep 3, 2026.
What is the net insider flow at BMRN over the last 6 months?
Over the trailing 180 days, insiders at BMRN have net sold $2.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BMRN in the current window?
Inside the rolling window, insiders at BMRN bought $0 and sold $4.3M based on SEC Form 4 filings.
Can I get alerts for BMRN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BIOMARIN PHARMACEUTICAL INC (BMRN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BIOMARIN PHARMACEUTICAL INC is in the Healthcare sector.